Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags ALGONQUIN

Tag: ALGONQUIN

ASH 2020: Potential of Belantamab Mafodotin in Combination Standard Therapies in...

ADC Review | Editorial Team
Multiple myeloma is the second most common hematological malignancy in the United States and is generally considered treatable, but not curable. Multiple myeloma...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X